Association of Type II Diabetes Mellitus with Hepatocellular Carcinoma Occurrence - a Case Control Study from Kathmandu Valley
Authors:
- Dipendra Kumar JhaDJDipendra Kumar Jha
- Ankush MittalAMAnkush Mittal
- Satrudhan Pd. GuptaSGSatrudhan Pd. Gupta
- Dipendra Raj PandeyaDPDipendra Raj Pandeya
- Brijesh SathianBSBrijesh Sathian
Open Access
- 31 October 2012
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 13 (10) , 5097-5099
Abstract
To assess associations of Type II DM with hepatocellular carcinoma occurrence in Nepal. This case control study was carried out using data retrieved from the register maintained in the Department of Biochemistry of Nepalese Army Institute of Health Sciences between 1st January, 2012, and 31st August, 2012. The variables collected were age, gender, HbA1c. All biochemical parameters were analyzed in the Central Laboratory of our hospital by standard validated methods. One way ANOVA was used to examine the statistical significant difference between groups with the LSD post-hoc test for comparison of means of case groups. Odds ratios (OR) were calculated using simple logistic-regression analysis. Etiological factors for HCC were HBV, HCV, alcohol and cryptogenic cirrhosis. The highest age group belonged to the etiological category of HCV with a mean of 71.9 ± 3.6 (CI 69.3, 74.5) years and the lowest age group to the etiological category of HBV with 61.7 ± 5.3(CI 57.9, 65.5) years. The main imperative basis of HCC in present study was HCV (39.5%) and second most significant cause of HCC was alcohol (26%). Glycated hemoglobin was found to be more in males with HCC (7.9%) as compared to females (7.3%). The percentage of Type II diabetes mellitus was greater in HCC patients when compared to controls. This difference was statistically significant with an odd ratio of 4.63 (p<0.001). Type II DM influences incidence, risk of recurrence, overall survival, and treatment-related complications in HCC patients.Keywords
This publication has 10 references indexed in Scilit:
- Association Between MDM2 Promoter SNP309 T/G Polymorphism and Liver Cancer Risk - a Meta-analysisAsian Pacific Journal of Cancer Prevention, 2012
- Clinicopathological Characteristics of Hepatocellular Carcinoma in TurkeyAsian Pacific Journal of Cancer Prevention, 2012
- Recurrence after Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma: A Meta-analysisAsian Pacific Journal of Cancer Prevention, 2012
- Effect of Insulin-like Growth Factor-1 on Bone Morphogenetic Protein-2 Expression in Hepatic Carcinoma SMMC7721 Cells through the p38 MAPK Signaling PathwayAsian Pacific Journal of Cancer Prevention, 2012
- Risk Factors of Hepatocellular Carcinoma - Current Status and PerspectivesAsian Pacific Journal of Cancer Prevention, 2012
- STATs in cancer inflammation and immunity: a leading role for STAT3Nature Reviews Cancer, 2009
- Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulinWorld Journal of Gastroenterology, 2008
- Glucose Modulates Basement Membrane Fibroblast Growth Factor-2 via Alterations in Endothelial Cell PermeabilityJournal of Biological Chemistry, 2007
- Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancerNature Clinical Practice Oncology, 2005
- Improved Method for Analysis of Glycated Haemoglobin by Ion Exchange ChromatographyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1994